PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway

Current lung cancer treatments are far from satisfactory; thus, finding novel treatment targets is crucial. We recently identified procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3), which is involved in fibrosis and tissue remodeling as a radioresistance-related protein in lung cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Jeong-Hwa, Yun, Hong Shik, Kwon, Gyoo Taik, Lee, Janet, Kim, Ju-Young, Jo, Yunhui, Cho, Jae-Min, Lee, Chang-Woo, Song, Jie-Young, Ahn, Jiyeon, Kim, Jae-Sung, Kim, Eun Ho, Hwang, Sang-Gu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377650/
https://www.ncbi.nlm.nih.gov/pubmed/30770789
http://dx.doi.org/10.1038/s41419-019-1405-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377650/
https://www.ncbi.nlm.nih.gov/pubmed/30770789
http://dx.doi.org/10.1038/s41419-019-1405-8

Ejemplares similares